Movement Alert｜Tempus AI Rises 5.39% in Regular Trading, Multiple Catalysts Propel AI Healthcare Leader to New Highs

Market Focus09-17 21:49

On September 17, Tempus AI rose 5.39% in regular trading, trading at $76.16/share with turnover of $179 million, extending a strong upward trend that has pushed the stock well above the consensus analyst target price range.

The rally is driven by a confluence of positive developments. On September 11, Tempus AI announced plans to build the world's largest multimodal whole-genome dataset, initially comprising 100,000 whole genome sequences paired with longitudinal clinical data, with a long-term goal of expanding to 1 million genomes. General availability is planned for mid-2027. On September 10, the company was selected by the Advanced Research Projects Agency for Health (ARPA-H) to receive up to $9.5 million to develop an autonomous clinical AI agent for heart-failure care. These catalysts build on the earlier FDA 510(k) clearance of its AI-enabled pulmonary hypertension detection product and a Q2 earnings beat, where adjusted EPS of -$0.04 topped the -$0.14 consensus estimate by over 71%, while revenue of $382.5 million exceeded expectations. The company also raised full-year revenue guidance to $1.60-$1.61 billion.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1190148969?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-09-17 21:49","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1190148969","market":"hk","top_or_hot":-1,"title":"Movement Alert｜Tempus AI Rises 5.39% in Regular Trading, Multiple Catalysts Propel AI Healthcare Leader to New Highs","media":"Market Focus","content":"<p><p>On September 17, Tempus AI rose 5.39% in regular trading, trading at $76.16/share with turnover of $179 million, extending a strong upward trend that has pushed the stock well above the consensus analyst target price range.</p><p>The rally is driven by a confluence of positive developments. On September 11, Tempus AI announced plans to build the world's largest multimodal whole-genome dataset, initially comprising 100,000 whole genome sequences paired with longitudinal clinical data, with a long-term goal of expanding to 1 million genomes. General availability is planned for mid-2027. On September 10, the company was selected by the Advanced Research Projects Agency for Health (ARPA-H) to receive up to $9.5 million to develop an autonomous clinical AI agent for heart-failure care. These catalysts build on the earlier FDA 510(k) clearance of its AI-enabled pulmonary hypertension detection product and a Q2 earnings beat, where adjusted EPS of -$0.04 topped the -$0.14 consensus estimate by over 71%, while revenue of $382.5 million exceeded expectations. The company also raised full-year revenue guidance to $1.60-$1.61 billion.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Tempus AI Rises 5.39% in Regular Trading, Multiple Catalysts Propel AI Healthcare Leader to New Highs</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Tempus AI Rises 5.39% in Regular Trading, Multiple Catalysts Propel AI Healthcare Leader to New Highs\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-09-17 21:49</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On September 17, Tempus AI rose 5.39% in regular trading, trading at $76.16/share with turnover of $179 million, extending a strong upward trend that has pushed the stock well above the consensus analyst target price range.</p><p>The rally is driven by a confluence of positive developments. On September 11, Tempus AI announced plans to build the world's largest multimodal whole-genome dataset, initially comprising 100,000 whole genome sequences paired with longitudinal clinical data, with a long-term goal of expanding to 1 million genomes. General availability is planned for mid-2027. On September 10, the company was selected by the Advanced Research Projects Agency for Health (ARPA-H) to receive up to $9.5 million to develop an autonomous clinical AI agent for heart-failure care. These catalysts build on the earlier FDA 510(k) clearance of its AI-enabled pulmonary hypertension detection product and a Q2 earnings beat, where adjusted EPS of -$0.04 topped the -$0.14 consensus estimate by over 71%, while revenue of $382.5 million exceeded expectations. The company also raised full-year revenue guidance to $1.60-$1.61 billion.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TEM","symbol_name":"Tempus AI","start_time":0,"source_url":"","article_id":"1190148969","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1190148969","pubTimestamp":1789652946,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On September 17, Tempus AI rose 5.39% in regular trading, trading at $76.16/share with turnover of $179 million, extending a strong upward trend that has pushed the stock well above the consensus...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"TEM":"Tempus AI"},"translate_title":"走势提醒|腾邦人工智能常规交易上涨5.39%，多重催化剂推动人工智能医疗龙头再创新高","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TEM":1},"content_text":"On September 17, Tempus AI rose 5.39% in regular trading, trading at $76.16/share with turnover of $179 million, extending a strong upward trend that has pushed the stock well above the consensus analyst target price range.The rally is driven by a confluence of positive developments. On September 11, Tempus AI announced plans to build the world's largest multimodal whole-genome dataset, initially comprising 100,000 whole genome sequences paired with longitudinal clinical data, with a long-term goal of expanding to 1 million genomes. General availability is planned for mid-2027. On September 10, the company was selected by the Advanced Research Projects Agency for Health (ARPA-H) to receive up to $9.5 million to develop an autonomous clinical AI agent for heart-failure care. These catalysts build on the earlier FDA 510(k) clearance of its AI-enabled pulmonary hypertension detection product and a Q2 earnings beat, where adjusted EPS of -$0.04 topped the -$0.14 consensus estimate by over 71%, while revenue of $382.5 million exceeded expectations. The company also raised full-year revenue guidance to $1.60-$1.61 billion.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"productRelease","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.0","shortVersion":"4.50.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1190148969","isCrawlerRequest":true}